NCT02288312View on ClinicalTrials.gov

Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Epilepsy

Interventions

DRUG

BIA 2-093

All Listed Sponsors

lead

Bial - Portela C S.A.

INDUSTRY

NCT02288312 - Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate | Biotech Hunter | Biotech Hunter